Abstract
Context A gluten-free diet (GFD) is the recommended treatment for gluten-dependent disease. In addition, gluten withdrawal is popular and occasionally is suggested as a treatment for other autoimmune diseases (ADs). Objective The current systematic review summarizes those entities and discusses the logic behind using a GFD in classical non-gluten-dependentADs. Data Sources A search for medical articles in PubMed/MEDLINE, Web of Sciences, LILACS, and Scielo published between 1960 and 2020 was conducted, using the key words for various ADs and GFDs. Data Exxtraction Eight-three articles were included in the systematic review (using PRISMA guidelines). Data Analysis Reduction in symptoms of ADs after observance of a GFD was observed in 911 out of 1408 patients (64.7 and in 66 out of the 83 selected studies (79.5. The age of the patients ranged from 9 months to 69 years. The duration of the GFD varied from 1 month to 9 years. A GFD can suppress several harmful intraluminal intestinal events. Potential mechanisms and pathways for the action of GFD in the gut - remote organs' axis have been suggested. Conclusion A GFD might represent a novel nutritional therapeutic strategy for classical non-gluten-dependent autoimmune conditions.
| Original language | English |
|---|---|
| Pages (from-to) | 525-543 |
| Number of pages | 19 |
| Journal | Nutrition Reviews |
| Volume | 80 |
| Issue number | 3 |
| DOIs | |
| State | Published - 10 Feb 2022 |
| Externally published | Yes |
Keywords
- autoimmune disease
- gluten-free diet
- gluten withdrawal
- gut-brain axes
- gut -peripheral organs axes
- microbiome
- dysbiome ratio
- non-celiac autoimmune disease